FRG2C: A Drug Target / Disease Biomarker (G100288801)

Target Name: FRG2C

NCBI ID: G100288801

FRG2C

FRG2C: A Drug Target / Disease Biomarker

FRG2C, also known as FGFR2C, is a protein that is expressed in various tissues throughout the body, including the skin, hair, and nails. It is a member of the FGF (fibroblast growth factor) family, which is a group of proteins that are involved in cell growth and differentiation.

One of the things that makes FRG2C so interesting as a drug target is its role in the development and progression of various diseases, including cancer. FRG2C has been shown to be involved in the development of various types of cancer, including skin, lung, and ovarian cancer.

In addition to its role in cancer, FRG2C is also thought to be involved in the development and progression of other diseases, including autoimmune disorders and skin conditions.

FRG2C is also a good candidate as a biomarker for certain types of cancer, as it has been shown to be elevated in the blood and other body fluids in individuals with certain types of cancer. This makes it a potentially useful tool for the diagnosis and treatment of these diseases.

Overall, FRG2C is a protein that is both fascinating and important, and its potential as a drug target and biomarker make it an attractive target for researchers to investigate further.

Protein Name: FSHD Region Gene 2 Family Member C

The "FRG2C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRG2C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets